Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-024140
Filing Date
2025-08-14
Accepted
2025-08-14 17:00:21
Documents
71
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1639384
2 EX-31.1 ex31-1.htm EX-31.1 18637
3 EX-31.2 ex31-2.htm EX-31.2 18498
4 EX-32.1 ex32-1.htm EX-32.1 8564
5 EX-32.2 ex32-2.htm EX-32.2 8713
  Complete submission text file 0001641172-25-024140.txt   8085323

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdt-20250630.xsd EX-101.SCH 53708
7 XBRL CALCULATION FILE cdt-20250630_cal.xml EX-101.CAL 65267
8 XBRL DEFINITION FILE cdt-20250630_def.xml EX-101.DEF 298031
9 XBRL LABEL FILE cdt-20250630_lab.xml EX-101.LAB 490365
10 XBRL PRESENTATION FILE cdt-20250630_pre.xml EX-101.PRE 396546
73 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1280822
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CDT Equity Inc. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41245 | Film No.: 251220661
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)